Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

99 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Clinical, Radiological, and Histopathological Characteristics of Periosteal Chondrosarcoma with a Focus on the Frequency of Medullary Invasion.
Nakagawa M, Endo M, Susuki Y, Yokoyama N, Maekawa A, Nabeshima A, Iida K, Fujiwara T, Setsu N, Matsunobu T, Matsumoto Y, Yokoyama R, Yamada Y, Kohashi K, Yamamoto H, Oda Y, Iwamoto Y, Nakashima Y. Nakagawa M, et al. Among authors: nabeshima a. J Clin Med. 2022 Apr 6;11(7):2062. doi: 10.3390/jcm11072062. J Clin Med. 2022. PMID: 35407670 Free PMC article.
Older age at surgery and postoperative leg length discrepancy are risk factors for unfavourable patient-reported outcome measures of knee tumour endoprostheses following resection for musculoskeletal tumour of the lower limb.
Kokubu Y, Fujiwara T, Matsumoto Y, Endo M, Setsu N, Iida K, Nabeshima A, Nakashima Y. Kokubu Y, et al. Among authors: nabeshima a. Bone Jt Open. 2023 Dec 1;4(12):906-913. doi: 10.1302/2633-1462.412.BJO-2023-0125.R1. Bone Jt Open. 2023. PMID: 38035606 Free PMC article.
Methylation-mediated silencing of protein kinase C zeta induces apoptosis avoidance through ATM/CHK2 inactivation in dedifferentiated chondrosarcoma.
Shimada E, Matsumoto Y, Nakagawa M, Susuki Y, Endo M, Setsu N, Fujiwara T, Iida K, Nabeshima A, Yahiro K, Kimura A, Hirose T, Kanahori M, Oyama R, Oda Y, Nakashima Y. Shimada E, et al. Among authors: nabeshima a. Br J Cancer. 2022 May;126(9):1289-1300. doi: 10.1038/s41416-021-01695-1. Epub 2022 Jan 11. Br J Cancer. 2022. PMID: 35017658 Free PMC article.
Does the Use of Peripheral Immune-Related Markers Indicate Whether to Administer Pazopanib, Trabectedin, or Eribulin to Advanced Soft Tissue Sarcoma Patients?
Shimada E, Endo M, Matsumoto Y, Tsuchihashi K, Ito M, Kusaba H, Nabeshima A, Nawata T, Maekawa A, Matsunobu T, Setsu N, Fujiwara T, Iida K, Nakagawa M, Hirose T, Kanahori M, Oyama R, Isobe T, Ariyama H, Kohashi K, Yamamoto H, Oda Y, Iwamoto Y, Akashi K, Baba E, Nakashima Y. Shimada E, et al. Among authors: nabeshima a. J Clin Med. 2021 Oct 26;10(21):4972. doi: 10.3390/jcm10214972. J Clin Med. 2021. PMID: 34768491 Free PMC article.
99 results